Literature DB >> 707697

Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively.

S Koga, H Kishimoto, K Tanaka, H Kawaguchi.   

Abstract

From the clinical and pathologic findings, the characteristics of recurrence of gastric cancer more than five years postoperatively were evaluated as compared with recurrence of less than five years postoperatively. The late (more than 5 years postoperative) recurrence rate was 2.0 per cent, or 17 of 864 patients who had undergone the so-called radical operation. The duration of disease prior to the first operation was comparatively long in the patients with late recurrence. Late recurrence is characteristic of localized cancer, such as Borrmann's type II, and differentiated adenocarcinoma with nonserosal invasion (pathologic findings of the resected stomach at the first operation) and by a recurrence pattern of hematogenous metastasis, especially liver metastasis.

Entities:  

Mesh:

Year:  1978        PMID: 707697     DOI: 10.1016/0002-9610(78)90284-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

Authors:  F Bozzetti; E Marubini; G Bonfanti; R Miceli; C Piano; L Gennari
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

2.  Adjuvant chemotherapy in gastric cancer.

Authors:  P Schlag
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

3.  Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection?

Authors:  Ulysses Ribeiro; Adriana V Safatle-Ribeiro; Bruno Zilberstein; Donato Mucerino; Osmar Kenji Yagi; Cláudio Caldas Bresciani; Carlos Eduardo Jacob; Kyioshi Iryia; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

4.  Obstructive jaundice in gastric carcinoma: cause, site, and relationship to the primary lesion.

Authors:  B H Lee; S Y Chin; S A Kim; K H Kim; Y S Do
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

5.  Adequacy of margins of resection in gastrectomy for cancer.

Authors:  F Bozzetti; G Bonfanti; R Bufalino; V Menotti; S Persano; S Andreola; R Doci; L Gennari
Journal:  Ann Surg       Date:  1982-12       Impact factor: 12.969

6.  Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability.

Authors:  S Koga; N Kaibara; H Kishimoto; H Nishidoi; O Kimura; T Okamoto; H Tamura
Journal:  Langenbecks Arch Chir       Date:  1982

7.  Carcinoma of the stomach. Why are we falling to improve survival?

Authors:  T E Weed; W Nuessle; A Ochsner
Journal:  Ann Surg       Date:  1981-04       Impact factor: 12.969

8.  Lower survival rate for patients under 30 years of age and surgically treated for gastric carcinoma.

Authors:  Y Maehara; H Orita; S Moriguchi; Y Emi; M Haraguchi; K Sugimachi
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

9.  Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer.

Authors:  U Ribeiro; J J Gama-Rodrigues; A V Safatle-Ribeiro; B Bitelman; R E Ibrahim; M B Ferreira; A A Laudanna; H W Pinotti
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.